Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Allen Kaplan

Allergy & Immunology North Charleston, SC Medical Doctor

NPI 1124007661 CMS profile 141022

9165 University Blvd, North Charleston, SC 29406

Open in the dashboard

General payments

$220,157

178 records reported · program years 2019–2025

Research payments

$26,531

Paid to them · 13 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Allen Kaplan of North Charleston, SC is reported in the CMS Open Payments database as having received $220,157 across 178 general payments and $26,531 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $22,732 28
2025 Research $21,681 12
2024 General $21,913 19
2023 General $41,802 34
2022 General $10,070 15
2022 Research $4,850 1
2021 General $27,543 15
2020 General $42,007 19
2019 General $54,089 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Allen Kaplan
  • Allergy & Immunology median
  • Middle half of Allergy & Immunology
  • National median

In program year 2025, general payments to Allen Kaplan were reported at $22,732. Among 2,466 Allergy & Immunology profiles paid that year, the median was $1,140 and the middle half received between $272 and $2,892.

Show as a table
Year Allen Kaplan Allergy & Immunology median Middle half National median
2019 $54,089 $594 $163–$1,512 $163
2020 $42,007 $426 $106–$1,233 $114
2021 $27,543 $638 $157–$1,708 $132
2022 $10,070 $790 $205–$1,961 $149
2023 $41,802 $852 $220–$2,147 $160
2024 $21,913 $865 $203–$2,267 $164
2025 $22,732 $1,140 $272–$2,892 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CSL Behring $79,601 66 payments
  2. Novartis Pharmaceuticals Corporation $29,027 36 payments
  3. Pharming Healthcare, Inc. $25,024 12 payments
  4. Genzyme Corporation $19,795 10 payments
  5. Novartis Pharma AG $14,987 3 payments
  6. Genentech, Inc. $9,204 3 payments
  7. Fresenius Kabi USA, LLC $7,088 5 payments
  8. BioCryst US Sales Co., LLC $6,812 5 payments
  9. Sanofi US Services Inc. $4,506 4 payments
  10. Roche Products Limited $4,158 5 payments
  11. Other $19,956 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $101,845 42 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $53,720 14 payments
  3. Honoraria $32,968 14 payments
  4. Travel and Lodging $24,053 45 payments
  5. Food and Beverage $3,961 60 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $3,500 1 payment
  7. Education $110 2 payments
Products named General payments · program years 2019–2025
  1. Haegarda $32,201 45 payments
  2. RUCONEST $23,074 11 payments
  3. DUPIXENT $13,605 5 payments
  4. LCZ696D_ENTRESTO_CARDIOVASCULAR $10,082 2 payments
  5. Xolair $7,182 5 payments
  6. PH-Icatibant $7,088 5 payments
  7. Andembry $6,473 7 payments
  8. ENTRESTO $4,905 1 payment
  9. QGE031 $3,815 1 payment
  10. Orladeyo $3,120 4 payments
  11. Other $14,421 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Novartis Pharma AG $20,581 9 payments
  2. Novartis Pharmaceuticals Corporation $4,850 1 payment
  3. AbbVie, Inc. $1,100 3 payments

Records

191 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Allergy & Immunology in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record